Mirae Asset Global ETFs Holdings
VKTX icon

Mirae Asset Global ETFs Holdings’s Viking Therapeutics VKTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Buy
11,555
+2,618
+29% +$84.6K ﹤0.01% 2057
2026
Q1 		$267K Sell
8,937
-143
-2% -$4.6K ﹤0.01% 2198
2025
Q4 		$321K Sell
9,080
-1,115
-11% -$39.5K ﹤0.01% 2121
2025
Q3 		$263K Buy
10,195
+2,502
+33% +$74.6K ﹤0.01% 2183
2025
Q2 		$204K Sell
7,693
-863
-10% -$22.7K ﹤0.01% 2273
2025
Q1 		$219K Sell
8,556
-2,241
-21% -$70.8K ﹤0.01% 2278
2024
Q4 		$429K Buy
+10,797
New +$616K ﹤0.01% 1997
2024
Q3 		– Sell
-64,820
Closed -$3.41M – 3189
2024
Q2 		$3.41M Buy
+64,820
New +$4.25M 0.01% 881

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's VKTX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Viking Therapeutics (VKTX) stake by 29% in Q2 2026, buying an estimated $84.6K and bringing the position to 11,555 shares worth $457K. The position accounts for ﹤0.01% of the portfolio, ranked #2057.

Mirae Asset Global ETFs Holdings first reported a position in VKTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.41M in Q2 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 11,555 shares of Viking Therapeutics worth $457K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 2,618 Viking Therapeutics shares in Q2 2026, an estimated $84.6K.
  • Viking Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2057 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Viking Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Viking Therapeutics position peaked at $3.41M in Q2 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.